Madarimot, Delma R.

HRN: 23-46-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2023
CEFTRIAXONE 1G (VIAL)
10/11/2023
10/17/2023
IV
2gms
OD
UTI
Waiting Final Action 
10/23/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/23/2023
10/29/2023
IV
4.5gm
IV
Septicemia
Waiting Final Action 
10/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/30/2023
11/13/2023
IV
500mg
Q8hrs
S/P Ex Lap For Abdominal Abscess
Waiting Final Action 
11/02/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/02/2023
11/08/2023
IVT
4.5gm
Q8
Intraabdominal Interloop Abscesses With Fistula Tract; S/p Exlap; For Re-exlap
Waiting Final Action 
11/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/02/2023
11/08/2023
IVT
500mg
Q8
Intraabdominal Interloop Abscesses With Fistula Tract; S/p Exlap; For Re-exlap
Waiting Final Action 
11/03/2023
CEFTAZIDIME 1GM (VIAL)
11/03/2023
11/10/2023
IV
2 Grams
Q8H
S/P Re-ExLap For Abdominal Abcess
Waiting Final Action 
11/10/2023
MUPIROCIN 2%, 15G (TUBE)
11/10/2023
11/17/2023
TOPICAL
Topical
2%
Pressure Ulcer
Waiting Final Action 
11/17/2023
CEFTAZIDIME 1GM (VIAL)
11/17/2023
11/22/2023
IV
2g
Q8
Intraabdominal Abscess
Waiting Final Action 
11/18/2023
MUPIROCIN 2%, 15G (TUBE)
11/18/2023
11/24/2023
TOPICAL
Thinly
BID
Skin Infection
Waiting Final Action 
11/19/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
11/19/2023
11/26/2023
IV
500mg
IV
Intra-Abdominal Infection
Waiting Final Action 
12/22/2023
CEFIXIME 200MG (CAP)
12/22/2023
12/29/2023
PO
200mg
Every 12hours
Empiric
Waiting Final Action 
12/22/2023
METRONIDAZOLE 500MG (TAB)
12/22/2023
12/29/2023
PO
500mg
Every 8hours
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: